Nasus Net Income Per Share from 2010 to 2026
| NSRX Stock | 5.59 0.09 1.64% |
Net Loss | First Reported 2010-12-31 | Previous Quarter (0.15) | Current Value (0.16) | Quarterly Volatility 0.02019977 |
Check Nasus Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nasus Pharma's main balance sheet or income statement drivers, such as Interest Expense of 35.2 K, Selling General Administrative of 599.7 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0. Nasus financial statements analysis is a perfect complement when working with Nasus Pharma Valuation or Volatility modules.
Nasus | Net Income Per Share | Build AI portfolio with Nasus Stock |
Latest Nasus Pharma's Net Income Per Share Growth Pattern
Below is the plot of the Net Income Per Share of Nasus Pharma over the last few years. It is Nasus Pharma's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nasus Pharma's overall financial position and show how it may be relating to other accounts over time.
| Net Income Per Share | 10 Years Trend |
|
Net Income Per Share |
| Timeline |
Nasus Net Income Per Share Regression Statistics
| Arithmetic Mean | (0.18) | |
| Coefficient Of Variation | (11.26) | |
| Mean Deviation | 0.01 | |
| Median | (0.19) | |
| Standard Deviation | 0.02 | |
| Sample Variance | 0.0004 | |
| Range | 0.0729 | |
| R-Value | 0.60 | |
| Mean Square Error | 0.0003 | |
| R-Squared | 0.36 | |
| Significance | 0.01 | |
| Slope | 0 | |
| Total Sum of Squares | 0.01 |
Nasus Net Income Per Share History
About Nasus Pharma Financial Statements
Nasus Pharma investors use historical fundamental indicators, such as Nasus Pharma's Net Income Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nasus Pharma. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | (0.15) | (0.16) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nasus Stock Analysis
When running Nasus Pharma's price analysis, check to measure Nasus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nasus Pharma is operating at the current time. Most of Nasus Pharma's value examination focuses on studying past and present price action to predict the probability of Nasus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nasus Pharma's price. Additionally, you may evaluate how the addition of Nasus Pharma to your portfolios can decrease your overall portfolio volatility.